Life stages ↗The follicle pool declines
Fewer and less consistently responsive follicles alter inhibin, FSH, estradiol, ovulation, and corpus-luteum patterns across perimenopause.
LIFE STAGES / 05
A transition.
Not a single hormone cliff.
Ovarian follicle decline changes ovulation, cycles, and steroid patterns before the final menstrual period. Thermoregulation, sleep, reproductive tissues, bone, and cardiometabolic context respond differently across people.
ESTABLISHEDOvarian transition physiology.
NORMAL VARIATIONSymptoms and trajectories.
DISEASE CONTEXTBleeding and bone boundaries.
LIMITED / MIXEDBiomarkers and universal claims.
Hormones can fluctuate before remaining lower
Estradiol and gonadotropins may vary markedly across cycles, so a single measurement often cannot summarize the transition.
Cycle length and flow can change
Shorter, longer, skipped, lighter, or heavier cycles can occur during transition, but normal-range change is not the only possible explanation.
Menopause is retrospective
Natural menopause is recognized after 12 consecutive months without menstruation when pregnancy, medication, illness, and other causes do not explain it.
Thermoregulatory symptoms vary
Hot flashes and night sweats reflect altered thermoregulatory control. Frequency, severity, duration, triggers, and impact differ greatly.
Sleep and mood have many inputs
Night sweats, circadian state, apnea, stress, caregiving, mood disorders, medicines, pain, and other health factors can overlap.
Genitourinary tissues respond to lower estrogen
Vulvar, vaginal, urethral, bladder, pelvic, sensory, and sexual-function changes can include dryness, discomfort, urinary symptoms, and recurrent infection context.
Bone loss can accelerate
Reduced estrogen contributes to faster remodeling imbalance, but bone strength and fracture risk also reflect age, prior bone, loading, nutrition, disease, medicines, and falls.
Bleeding after menopause is not expected physiology
Postmenopausal bleeding and concerning perimenopausal bleeding need evaluation for structural, endometrial, medication, pregnancy, and other causes.
Early loss of ovarian function is distinct
Primary ovarian insufficiency, surgical menopause, and treatment-induced menopause differ from natural midlife transition in timing, causes, and management.
One test cannot certify menopause for everyone
Cycle pattern, age, symptoms, anatomy, medications, and clinical context determine whether and when laboratory testing is informative.
Options answer different goals
Systemic hormones, local vaginal therapy, and nonhormonal options differ by symptom target, route, dose, anatomy, contraindications, benefits, and risks; compounded products are not automatically safer.